ENSACOVE
Active substance: ensartinib
CAPSULE · ENSARTINIB HYDROCHLORIDE 25 mg/1
United StatesActive
Marketing holder: Xcovery Holdings, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ENSARTINIB HYDROCHLORIDE · 25 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1209a-4a21-798c-aa6a-2911ad9f00f2,01a1209c-6d08-7cf8-9744-28fb9326e644;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 83076-1025
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 83076-1025 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 83076-1025 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 83076-1025 · Verified 2026-10-09 · open in source